AXSM 8-K 2026-11-02

Axsome Therapeutics, Inc. (AXSM) 8-K dated 2026-11-02 — accession 0001193125-26-442628.

Axsome Therapeutics, Inc. (AXSM) is a biotechnology company listed on US.

AXSM: SECURITIES AND EXCHANGE COMMISSION

This 8-K covers: Results of operations (Item 2.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported AXSM revenue for 2025-12-31 was $638.5M. Net income was -$183.2M. Revenue was up 65.5% from 2024-12-31 to 2025-12-31. AXSM currently screens at market cap $11.96B.

Not investment advice. The AXSM SEC hub lists recent forms. The stock page is the research view.